Prostate Cancer Patients Clinical Trials

4 recruiting

Prostate Cancer Patients Trials at a Glance

19 actively recruiting trials for prostate cancer patients are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Myrtle Beach, New York, and Madison. Lead sponsors running prostate cancer patients studies include Candel Therapeutics, Inc., Cellvax Therapeutics Inc, and Ashutosh Kumar Tewari.

Browse prostate cancer patients trials by phase

Treatments under study

About Prostate Cancer Patients Clinical Trials

Looking for clinical trials for Prostate Cancer Patients? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prostate Cancer Patients trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prostate Cancer Patients clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting
Not Applicable

Cancer Survivors Program

Breast Cancer PatientsProstate Cancer Patients
Masaryk Memorial Cancer Institute200 enrolled1 locationNCT07253987
Recruiting

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Prostate CancerProstate Cancer MetastaticProstate Cancer (Adenocarcinoma)+3 more
Société Algérienne de Formation et Recherche en Oncologie2,000 enrolled24 locationsNCT07484971
Recruiting
Phase 3

64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

Prostate CancerCryotherapyProstate Cancer Recurrent+3 more
Clarity Pharmaceuticals Ltd220 enrolled28 locationsNCT06970847
Recruiting
Phase 1

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd78 enrolled1 locationNCT07514065
Recruiting
Phase 2

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Prostate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by Radiotherapy
Candel Therapeutics, Inc.45 enrolled7 locationsNCT07332000
Recruiting
Phase 1

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Metastatic Castration-resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancer Patients
K36 Therapeutics, Inc.144 enrolled13 locationsNCT07103018
Recruiting

SpaceOAR Post-Market Registry Study

Prostate Cancer Patients Treated by Radiotherapy
Sheffield Teaching Hospitals NHS Foundation Trust320 enrolled8 locationsNCT07300631
Recruiting
Not Applicable

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital35 enrolled1 locationNCT07130682
Recruiting
Phase 1

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Prostate Cancer PatientsRecurrent Prostate CancerOligometastatic Prostate Cancer (OMPC)+1 more
University of Wisconsin, Madison14 enrolled1 locationNCT07090148
Recruiting
Phase 2

Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

Prostate CancerProstate Cancer Patients Treated by Radiotherapy
Medical University of South Carolina46 enrolled1 locationNCT07325721
Recruiting
Not Applicable

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Locally Advanced Prostate CancerProstate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate Carcinoma+1 more
Rigshospitalet, Denmark1,016 enrolled3 locationsNCT07343349
Recruiting
Phase 2Phase 3

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine300 enrolled2 locationsNCT03258320
Recruiting
Not Applicable

Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer

Prostate Cancer Patients Undergoing Radical Prostatectomy
N.N. Alexandrov National Cancer Centre800 enrolled1 locationNCT07308990
Recruiting

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Prostate Cancer RecurrentProstate Cancer (Diagnosis)Prostate Cancer Patients Treated by Radiotherapy+1 more
University of Erlangen-Nürnberg Medical School200 enrolled3 locationsNCT07131956
Recruiting
Not Applicable

Evaluation of Needs of Patients and Care-givers During and After Radiotherapy of Patients With Prostate Cancer

Prostate Cancer Patients
Charite University, Berlin, Germany60 enrolled1 locationNCT07156903
Recruiting
Phase 1

A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer Patients
Xiaorong Sun40 enrolled1 locationNCT07135102
Recruiting
Not Applicable

The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients

Prostate CancerMetastatic Prostate CancerProstate Cancer (Post Prostatectomy)+2 more
Ludwig-Maximilians - University of Munich150 enrolled1 locationNCT07126860
Recruiting
Phase 2

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Prostate CancerProstate CancersProstate Cancer (Adenocarcinoma)+4 more
Cellvax Therapeutics Inc100 enrolled3 locationsNCT06636682
Recruiting
Phase 2

Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance

Prostate Cancer Patients on Active Surveillance
Ashutosh Kumar Tewari114 enrolled1 locationNCT06343077